Published 12-03-12
Issued by CSL Limited
The report details the company's performance across key corporate responsibility priority areas
CSL Limited has published its fourth Corporate Responsibility Report - Our Corporate Responsibility 2012 - available at
www.csl.com.au/about/corporate-responsibility.htm
The report details CSL’s performance across key corporate responsibility priority areas for the period 1 July 2011 and 30 June 2012. These priority areas include the Company’s research into new and improved medicines, ensuring the safety and quality of its broad portfolio of therapies, providing a positive and healthy work environment for employees, behaving responsibly in the global marketplace, providing charitable support for communities in need around the world and minimising the environmental impacts of its operations.
Highlights and statistics include:
The CSL Group has a combined heritage of outstanding contribution to medicine and human health with more than 95 years experience in the development and manufacture of vaccines and plasma protein biotherapies. With major facilities in Australia, Germany, Switzerland and the USA, CSL has over 11,000 employees working in more than 25 countries.
Please provide feedback on CSL’s Report at:
www.csl.com.au/about/corporate-responsibility.htm
require_once 'counter/results/hit.php'; //hits counter do not remove
?>